From the Director, Prof Chris Rowe
Welcome to the July edition of the ADNeT Newsletter.
A number of ADNeT members and I have recently attended the the Alzheimer’s Association International Conference. Amongst the highlights was Eli Lilly’s presentation on ground-breaking results from their Phase-3 clinical trial on new Alzheimer’s drug donanemab.
This month our Spotlight On segment features Dr Marita Long and Dr Stephanie Daly, who, as primary care physicians, share their experiences and insights into dementia diagnosis, treatment and care and how GPs can tackle some of the obstacles faced in diagnosing patients in a clinical setting. I really encourage you to read this insightful interview.
You can read the latest news by visiting the News section on our website.